Large Cap

Nebius Stock Soars On $17 Billion Microsoft Contract

Nebius Stock Soars On $17 Billion Microsoft Contract

AstraZeneca Lung Cancer Combo Extends Patient Survival By Years In Key Study

AstraZeneca Lung Cancer Combo Extends Patient Survival By Years In Key Study

Summit Therapeutics' Lung Cancer Drug Under Dark Clouds As Keytruda Challenger Shows Regional Data Differences

Summit Therapeutics' Lung Cancer Drug Under Dark Clouds As Keytruda Challenger Shows Regional Data Differences

AstraZeneca Lung Cancer Combo Extends Patient Survival By Years In Key Study

AstraZeneca Lung Cancer Combo Extends Patient Survival By Years In Key Study

Summit Therapeutics' Lung Cancer Drug Under Dark Clouds As Keytruda Challenger Shows Regional Data Differences

Summit Therapeutics' Lung Cancer Drug Under Dark Clouds As Keytruda Challenger Shows Regional Data Differences

Elon Musk's SpaceX Acquires EchoStar Spectrum To Transform Global Satellite Connectivity

Elon Musk's SpaceX Acquires EchoStar Spectrum To Transform Global Satellite Connectivity

Pfizer, BioNTech Roll Out COVID-19 Update That Boosts Antibodies 4-Fold In High-Risk Adults

Pfizer, BioNTech Roll Out COVID-19 Update That Boosts Antibodies 4-Fold In High-Risk Adults

Elon Musk's SpaceX Acquires EchoStar Spectrum To Transform Global Satellite Connectivity

Elon Musk's SpaceX Acquires EchoStar Spectrum To Transform Global Satellite Connectivity

Pfizer, BioNTech Roll Out COVID-19 Update That Boosts Antibodies 4-Fold In High-Risk Adults

Pfizer, BioNTech Roll Out COVID-19 Update That Boosts Antibodies 4-Fold In High-Risk Adults

Google Meet Outage Reported: What To Know

Google Meet Outage Reported: What To Know

BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy

BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy

Large Cap Recent News

PTC Therapeutics Could Challenge BioMarin For Metabolic Disorder Treatment

PTC Therapeutics Could Challenge BioMarin For Metabolic Disorder Treatment

BioMarin's Palynziq significantly lowered blood phenylalanine in teens with PKU, with nearly half reaching target levels in the Phase 3 study.

What's Happening With Regeneron Pharmaceuticals Stock On Monday?

What's Happening With Regeneron Pharmaceuticals Stock On Monday?

Regeneron's Phase 3 trials for cat and birch allergies show significant symptom relief and strong safety results, paving the way for future development.

Eli Lilly's Jaypirca Surpasses Chemoimmunotherapy For Untreated Blood Cancer Patients

Eli Lilly's Jaypirca Surpasses Chemoimmunotherapy For Untreated Blood Cancer Patients

Jaypirca outperformed chemoimmunotherapy in progression-free survival for chronic lymphocytic leukemia patients in a Phase 3 trial, with positive trends in overall survival.

Retail Investors' Top Stocks With Earnings This Week: GameStop, Oracle, Chewy And More

Retail Investors' Top Stocks With Earnings This Week: GameStop, Oracle, Chewy And More

Here's a look at the most notable companies set to report earnings this week, including Planet Labs, SailPoint and FuelCell Energy.

Alibaba Stock Climbs Over 3% In Monday Pre-Market: What's Going On?

Alibaba Stock Climbs Over 3% In Monday Pre-Market: What's Going On?

Alibaba Group Holding (NYSE: BABA) stock climbed 3.22% during the pre-market trading session on Monday after it launched its most extensive AI model to date, in a bid to compete with OpenAI and Google's (NASDAQ: GOOG) (NASDAQ: GOOGL) DeepMind

Federal Judge Dismisses Newsmax's Antitrust 'Shotgun Pleading' Complaint Against Fox News

Federal Judge Dismisses Newsmax's Antitrust 'Shotgun Pleading' Complaint Against Fox News

Newsmax's antitrust case against Fox was dismissed but it may refile, alleging Fox blocked competition and forced unfair distribution deals in news TV.

Europe Slaps $3.5 Billion Fine On Google, Donald Trump Says Money Could Instead Go To American Investments and Jobs

Europe Slaps $3.5 Billion Fine On Google, Donald Trump Says Money Could Instead Go To American Investments and Jobs

The European Commission fined Google €2.95 billion for breaching antitrust rules by favouring its own adtech services and limiting competition. Google must propose fixes within 60 days.

FDA Tightens Grip On Safe Weight Loss Drugs, WHO Adds Them To Essential Medicines List

FDA Tightens Grip On Safe Weight Loss Drugs, WHO Adds Them To Essential Medicines List

FDA introduces a green list to block unsafe GLP-1 drug imports, while WHO updates its essential medicines list to include diabetes and cancer treatments.

Streaming Shift Forces Paramount to Rethink Cable Networks' Future

Streaming Shift Forces Paramount to Rethink Cable Networks' Future

Paramount Skydance is working to revive MTV and other networks by expanding digital content, investing in premium shows, and cutting costs as viewers shift from cable to streaming services.

Figma And Lululemon Are Among Top 10 Large Cap Losers Last Week (September 1- September 5): Are The Others In Your Portfolio?

Figma And Lululemon Are Among Top 10 Large Cap Losers Last Week (September 1- September 5): Are The Others In Your Portfolio?

Figma, Lululemon, Duolingo, and other big names led last week's top 10 large-cap stock declines across sectors.

Wayfair, United Therapeutics, And Ciena Are Among The Top 10 Large-Cap Gainers Last Week (Sep. 1-Sep.5): Are The Others In Your Portfolio? (CORRECTED)

Wayfair, United Therapeutics, And Ciena Are Among The Top 10 Large-Cap Gainers Last Week (Sep. 1-Sep.5): Are The Others In Your Portfolio? (CORRECTED)

These ten large-cap stocks were top performers last week. Are they a part of your portfolio?

Apple Faces Class-Action Lawsuit Over Reported Use Of Copyrighted Books To Train AI

Apple Faces Class-Action Lawsuit Over Reported Use Of Copyrighted Books To Train AI

Apple faces a lawsuit for allegedly using copyrighted books without permission to train its OpenELM AI model.

Trump's Nvidia Export Deal Collides With AI GAIN Act — Chipmaker Warns New Bill Could Cripple Global Competition

Trump's Nvidia Export Deal Collides With AI GAIN Act — Chipmaker Warns New Bill Could Cripple Global Competition

Nvidia warned that a new U.S. bill could hurt its global edge by restricting AI chip exports, while growing pressure pushes tech firms like OpenAI to seek alternatives.